Financial Tearsheet

Company Overview

Recent Financial News

Date   Headline
May 14, 2020 Aytu BioScience Reports Third Quarter Fiscal 2020 Financial Results
May 07, 2020 Aytu BioScience to Report Fiscal Q3 FY 2020 Results and Business Update
Apr 30, 2020 Aytu BioScience Announces China Export Clearance of Company's COVID-19 IgG/IgM Rapid Test
Apr 27, 2020 Aytu BioScience Signs Development Agreement with Sterling Medical Devices to Advance the Development of Healight as a Potential Coronavirus Treatment
Apr 24, 2020 Aytu BioScience Announces Results from Annual Stockholders Meeting

IR Contacts

Hayden IR

James Carbonara
1441 Broadway
Fifth Floor
New York, NY 10018
Office: (646)-755-7412
James@haydenir.com

Stock Performance

Today's Open 1.38
Volume 9.24 million
Day Range 1.37 - 1.50
52 Week Range 0.34 - 2.99
Bid/Ask 1.46 / 1.47
Bid/Ask Size 20,900 X 124,500
Previous Close 1.40
Market Cap 179.19 million
Shares Outstanding 120.26 million
Dividend/Yield 0.00 / 0.00%
EPS (TTM) -1.313600
P/E Ratio (TTM) N/A

Recent XBRL Filings

Filing Date Form Type Description View
May 15, 2020 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Feb 14, 2020 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Nov 14, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Sep 26, 2019 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  
May 14, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  

Management Team

Josh Disbrow, Chairman & Chief Executive Officer

Jarrett Disbrow, Chief Operating Officer

David Green, Chief Financial Officer

Board of Directors

Josh Disbrow, Chairman & Chief Executive Officer

Gary Cantrell, Director, Chair, Compensation Committee

Carl Dockery, Director, Chair, Nominating & Governance Committee

John Donofrio, Jr., Director, Chair, Audit Committee

Michael Macaluso, Director